Advertisement

Endocrinopathic Laminitis

Published:October 18, 2021DOI:https://doi.org/10.1016/j.cveq.2021.08.001

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Veterinary Clinics: Equine Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Karikoski N.P.
        • Horn I.
        • McGowan T.W.
        • et al.
        The prevalence of endocrinopathic laminitis among horses presented for laminitis at a first-opinion/referral equine hospital.
        Domest Anim Endocrinol. 2011; 41: 111-117
        • McGowan T.W.
        • Pinchbeck G.P.
        • McGowan C.M.
        Prevalence, risk factors and clinical signs predictive for equine pituitary pars intermedia dysfunction in aged horses.
        Equine Vet J. 2013; 45: 74-79
        • Tadros E.M.
        • Fowlie J.G.
        • Refsal K.R.
        • et al.
        Association between hyperinsulinaemia and laminitis severity at the time of pituitary pars intermedia dysfunction diagnosis.
        Equine Vet J. 2019; 51: 52-56
        • Karikoski N.P.
        • Patterson-Kane J.C.
        • Singer E.R.
        • et al.
        Lamellar pathology in horses with pituitary pars intermedia dysfunction.
        Equine Vet J. 2016; 48: 472-478
        • Cornelisse C.J.
        • Robinson N.E.
        Glucocorticoid therapy and the risk of equine laminitis.
        Equine Vet Edu. 2013; 25: 39-46
        • Haseler C.J.
        • Jarvis G.E.
        • McGovern K.F.
        Intrasynovial triamcinolone treatment is not associated with incidence of acute laminitis..
        Equine Vet J. 2021; 53: 895-901
        • Jordan V.J.
        • Ireland J.L.
        • Rendle D.I.
        Does oral prednisolone treatment increase the incidence of acute laminitis?.
        Equine Vet J. 2017; 49: 19-25
        • Potter K.
        • Stevens K.
        • Menzies-Gow N.
        Prevalence of and risk factors for acute laminitis in horses treated with corticosteroids.
        Vet Rec. 2019; 185: 82
        • Menzies-Gow N.J.
        • Harris P.A.
        • Elliott J.
        Prospective cohort study evaluating risk factors for the development of pasture-associated laminitis in the United Kingdom.
        Equine Vet J. 2017; 49: 300-306
        • Coleman M.C.
        • Belknap J.K.
        • Eades S.C.
        • et al.
        Case-control study of risk factors for pasture-and endocrinopathy-associated laminitis in North American horses.
        J Am Vet Med Assoc. 2018; 253: 470-478
        • Durham A.E.
        • Frank N.
        • McGowan C.M.
        • et al.
        ECEIM consensus statement on equine metabolic syndrome.
        J Vet Intern Med. 2019; 33: 335-349
        • Engiles J.B.
        • Galantino-Homer H.
        • Boston R.
        • et al.
        Osteopathology in the equine distal phalanx associated with the development and progression of laminitis.
        J Vet Pathol. 2015; 52: 928-944
        • Karikoski N.P.
        • McGowan C.M.
        • Singer E.R.
        • et al.
        Pathology of natural cases of equine endocrinopathic laminitis associated with hyperinsulinemia.
        Vet Pathol. 2015; 52: 945-956
        • Cassimeris L.
        • Engiles J.B.
        • Galantino-Homer H.
        Detection of endoplasmic reticulum stress and the unfolded protein response in naturally-occurring endocrinopathic equine laminitis.
        BMC Vet Res. 2019; 15: 24
        • Meier A.
        • de Laat M.
        • Pollitt C.
        • et al.
        A "modified Obel" method for the severity scoring of (endocrinopathic) equine laminitis.
        PeerJ. 2019; 7: e7084
        • de Laat M.A.
        • Sillence M.N.
        • McGowan C.M.
        • et al.
        Continuous intravenous infusion of glucose induces endogenous hyperinsulinaemia and lamellar histopathology in Standardbred horses.
        Vet J. 2012; 191: 317-322
        • Asplin K.E.
        • Patterson-Kane J.C.
        • Sillence M.N.
        • et al.
        Histopathology of insulin-induced laminitis in ponies.
        Equine Vet J. 2010; 42: 700-706
        • Wylie C.E.
        • Collins S.N.
        • Verheyen K.L.P.
        • et al.
        Frequency of equine laminitis: a systematic review with quality appraisal of published evidence.
        Vet J. 2011; 189: 248-256
        • Frank N.F.
        • Bailey S.
        • Bertin F.R.
        • et al.
        Recommendations for the diagnosis and treatment of equine metabolic syndrome (EMS) from 2020 Equine Endocrinology Group.
        (Available at:) (Accessed August 19, 2020)
        • Thatcher C.D.
        • Pleasant R.S.
        • Geor R.J.
        • et al.
        Prevalence of obesity in mature horses: an equine body condition study.
        J Anim Physiol Anim Nutr. 2008; 92: 222
        • Pleasant R.S.
        • Suagee J.K.
        • Thatcher C.D.
        • et al.
        Adiposity, plasma insulin, leptin, lipids, and oxidative stress in mature light breed horses.
        J Vet Intern Med. 2013; 27: 576-582
        • Morgan R.A.
        • McGowan T.W.
        • McGowan C.M.
        Prevalence and risk factors for hyperinsulinaemia in ponies in Queensland, Australia.
        Aust Vet J. 2014; 92: 101-106
        • Tadros E.M.
        • Frank N.
        • De Witte F.G.
        • et al.
        Effects of intravenous lipopolysaccharide infusion on glucose and insulin dynamics in horses with equine metabolic syndrome.
        Am J Vet Res. 2013; 74: 1020-1029
        • Bertin F.R.
        • Ruffin-Taylor D.
        • Stewart A.J.
        Insulin dysregulation in horses with systemic inflammatory response syndrome.
        J Vet Intern Med. 2018; 32: 1420-1427
        • Wylie C.E.
        • Collins S.N.
        • Verheyen K.L.P.
        • et al.
        Risk factors for equine laminitis: a case-control study conducted in veterinary-registered horses and ponies in Great Britain between 2009 and 2011.
        Vet J. 2013 Oct; 198: 57-69
        • Hodge E.
        • Kowalski A.
        • Torcivia C.
        • et al.
        Effect of thyrotropin-releasing hormone stimulation testing on the oral sugar test in horses when performed as a combined protocol.
        J Vet Intern Med. 2019; 33: 2272-2279
        • de Laat M.A.
        • Sillence M.N.
        • Reiche D.B.
        Phenotypic, hormonal, and clinical characteristics of equine endocrinopathic laminitis.
        J Vet Intern Med. 2019; 33: 1456-1463
        • Fitzgerald D.M.
        • Anderson S.T.
        • Sillence M.N.
        • et al.
        The cresty neck score is an independent predictor of insulin dysregulation in ponies.
        PLoS One. 2019; 14: e0220203
        • Meier A.D.
        • de Laat M.A.
        • Reiche D.B.
        • et al.
        The oral glucose test predicts laminitis risk in ponies fed a diet high in nonstructural carbohydrates.
        Domest Anim Endocrinol. 2018; 63: 1-9
        • Sherlock C.
        • Parks A.
        Radiographic and radiological assessment of laminitis.
        Equine Vet Educ. 2013; 25: 524-535
        • Haffner J.C.
        Practical clinical research results to consider when testing for PPID in horses. In AAEP proceedings.
        (Available at:) (Accessed August 31, 2020)
        • Asplin K.E.
        • Sillence M.N.
        • Pollitt C.C.
        • et al.
        Induction of laminitis by prolonged hyperinsulinaemia in clinically normal ponies.
        Vet J. 2007; 174: 530-535
        • Sandow C.
        • Fugler L.A.
        • Leise B.
        • et al.
        Ex vivo effects of insulin on the structural integrity of equine digital lamellae.
        Equine Vet J. 2019; 51: 131-135
        • Watts M.R.
        • Hegedus O.C.
        • Eades S.C.
        • et al.
        Association of sustained supraphysiologic hyperinsulinemia and inflammatory signaling within the digital lamellae in light-breed horses.
        J Vet Intern Med. 2019; 33: 1483-1492
        • Rahnama S.
        • Vathsangam N.
        • Spence R.
        • et al.
        Effects of an anti-IGF-1 receptor monoclonal antibody on laminitis induced by prolonged hyperinsulinaemia in standardbred horses.
        PLoS One. 2020; 15: e0239261
        • Kullmann A.
        • Weber P.S.
        • Bishop J.B.
        • et al.
        Equine insulin receptor and insulin-like growth factor-1 receptor expression in digital lamellar tissue and insulin target tissues.
        Equine Vet J. 2016; 48: 626-632
        • Rahnama S.
        • Spence R.
        • Vathsangam N.
        • et al.
        Effects of insulin on IGF-1 receptors in equine lamellar tissue in vitro.
        Domest Anim Endocrinol. 2021; 74: 106530
        • Nanayakkara S.N.
        • Rahnama S.
        • Harris P.A.
        • et al.
        Characterization of insulin and IGF-1 receptor binding in equine liver and lamellar tissue: implications for endocrinopathic laminitis.
        Domest Anim Endocrinol. 2019; 66: 21-26
        • Baskerville C.L.
        • Chockalingham S.
        • Harris P.A.
        • et al.
        The effect of insulin on equine lamellar basal epithelial cells mediated by the insulin-like growth factor-1 receptor.
        PeerJ. 2018; 6: e5945
        • Lane H.E.
        • Burns T.A.
        • Hegedus O.C.
        • et al.
        Lamellar events related to insulin-like growth factor-1 receptor signalling in two models relevant to endocrinopathic laminitis.
        Equine Vet J. 2017; 49: 643-654
        • Stokes S.M.
        • Bertin F.R.
        • Stefanovski D.
        • et al.
        Lamellar energy metabolism and perfusion in the euglycaemic hyperinsulinaemic clamp model of equine laminitis.
        Equine Vet J. 2020; 52: 577-584
        • Morgan R.A.
        • Keen J.A.
        • Walker B.R.
        • et al.
        Vascular dysfunction in horses with endocrinopathic laminitis.
        PLoS One. 2016; 11: e0163815
        • Burns T.A.
        • Geor R.J.
        • Mudge M.C.
        • et al.
        Proinflammatory cytokine and chemokine gene expression profiles in subcutaneous and visceral adipose tissue depots of insulin-resistant and insulin-sensitive light breed horses.
        J Vet Intern Med. 2010; 24: 932-939
        • Burns T.A.
        • Nijveldt E.
        • Watts M.
        • et al.
        Systemic and local regulation of leptin in a model of endocrinopathic laminitis. In: 2019 ACVIM Forum Research Abstract Program.
        J Vet Intern Med. 2019; 33: 2375-2547
        • Campolo A.
        • Frantz M.W.
        • de Laat M.A.
        • et al.
        Differential proteomic expression of equine cardiac and lamellar tissue during insulin-induced laminitis.
        Front Vet Sci. 2020; 7: 308
        • Hood D.M.
        • Wagner I.P.
        • Taylor D.D.
        • et al.
        Voluntary limb-load distribution in horses with acute and chronic laminitis.
        Am J Vet Res. 2001; 62: 1393-1398
        • Gardner A.K.
        • van Eps A.W.
        • Watts M.R.
        • et al.
        A novel model to assess lamellar signaling relevant to preferential weight bearing in the horse.
        Vet J. 2017; 221: 62-67
        • Frank N.
        • Elliott S.B.
        • Boston R.C.
        Effects of long-term oral administration of levothyroxine sodium on glucose dynamics in healthy adult horses.
        Am J Vet Res. 2008; 69: 76-81
        • Tóth F.
        • Frank N.
        • Geor R.J.
        • et al.
        Effects of pretreatment with dexamethasone or levothyroxine sodium on endotoxin-induced alterations in glucose and insulin dynamics in horses.
        Am J Vet Res. 2010; 71: 60-68
        • Durham A.E.
        • Rendle D.I.
        • Newton J.E.
        The effect of metformin on measurements of insulin sensitivity and beta cell response in 18 horses and ponies with insulin resistance.
        Equine Vet J. 2008; 40: 493-500
        • Rendle D.I.
        • Rutledge F.
        • Hughes K.J.
        • et al.
        Effects of metformin hydrochloride on blood glucose and insulin responses to oral dextrose in horses.
        Equine Vet J. 2013; 45: 751-754
        • Tinworth K.D.
        • Edwards S.
        • Noble G.K.
        • et al.
        Pharmacokinetics of metformin after enteral administration in insulin-resistant ponies.
        Am J Vet Res. 2010; 71: 1201-1206
        • Meier A.
        • Reiche D.
        • de Laat M.
        • et al.
        The sodium-glucose co-transporter 2 inhibitor velagliflozin reduces hyperinsulinemia and prevents laminitis in insulin-dysregulated ponies.
        PLoS One. 2018; 13: e0203655
        • Legere R.M.
        • Taylor D.R.
        • Davis J.L.
        • et al.
        Pharmacodynamic effects of pioglitazone on high molecular weight adiponectin concentrations and insulin response after oral sugar in equids.
        J Equine Vet Sci. 2019; 82: 102797
        • Bamford N.J.
        • Potter S.J.
        • Baskerville C.L.
        • et al.
        Influence of dietary restriction and low-intensity exercise on weight loss and insulin sensitivity in obese equids.
        J Vet Intern Med. 2019; 33: 280-286
        • Freestone J.F.
        • Beadle R.
        • Shoemaker K.
        • et al.
        Improved insulin sensitivity in hyperinsulinaemic ponies through physical conditioning and controlled feed intake.
        Equine Vet J. 1992; 24: 187-190
        • Powell D.M.
        • Reedy S.E.
        • Sessions D.R.
        • et al.
        Effect of short-term exercise training on insulin sensitivity in obese and lean mares.
        Equine Vet J Suppl. 2002; : 81-84
        • Blikslager A.T.
        • Yin C.
        • Cochran A.M.
        • et al.
        Cyclooxygenase expression in the early stages of equine laminitis: a cytologic study.
        J Vet Intern Med. 2006; 20: 1191-1196
        • Stokes S.M.
        • Bertin F.R.
        • Stefanovski D.
        • et al.
        The effect of continuous digital hypothermia on lamellar energy metabolism and perfusion during laminitis development in two experimental models.
        Equine Vet J. 2020; 52: 585-592
        • Fugler L.A.
        • Eades S.C.
        • Moore R.M.
        • et al.
        Plasma matrix metalloproteinase activity in horses after intravenous infusion of lipopolysaccharide and treatment with matrix metalloproteinase inhibitors.
        Am J Vet Res. 2013; 74: 473-480
        • Ingle-Fehr J.E.
        • Baxter G.M.
        The effect of oral isoxsuprine and pentoxifylline on digital and laminar blood flow in healthy horses.
        Vet Surg. 1999; 28: 154-160
        • de Laat M.A.
        • Reiche D.B.
        • Sillence M.N.
        • et al.
        Incidence and risk factors for recurrence of endocrinopathic laminitis in horses.
        J Vet Intern Med. 2019; 33: 1473-1482
        • Luthersson N.
        • Mannfalk M.
        • Parkin T.D.H.
        • et al.
        Laminitis: risk factors and outcome in a group of Danish horses.
        J Equine Vet Sci. 2017; 53: 68-73
        • McGowan C.M.
        • Frost R.
        • Pfeiffer D.U.
        • et al.
        Serum insulin concentrations in horses with equine Cushing's syndrome: response to a cortisol inhibitor and prognostic value.
        Equine Vet J. 2004; 36: 295-298